165 related articles for article (PubMed ID: 38644421)
1. Prevotella intermedia boosts OSCC progression through ISG15 upregulation: a new target for intervention.
Qin Y; Li Z; Liu T; Ma J; Liu H; Zhou Y; Wang S; Zhang L; Peng Q; Ye P; Duan N; Wang W; Wang X
J Cancer Res Clin Oncol; 2024 Apr; 150(4):206. PubMed ID: 38644421
[TBL] [Abstract][Full Text] [Related]
2. Heat-killed Prevotella intermedia promotes the progression of oral squamous cell carcinoma by inhibiting the expression of tumor suppressors and affecting the tumor microenvironment.
Zhou Y; Qin Y; Ma J; Li Z; Heng W; Zhang L; Liu H; Li R; Zhang M; Peng Q; Ye P; Duan N; Liu T; Wang W; Wang X
Exp Hematol Oncol; 2024 Mar; 13(1):33. PubMed ID: 38515216
[TBL] [Abstract][Full Text] [Related]
3.
Liu S; Zhou X; Peng X; Li M; Ren B; Cheng G; Cheng L
J Immunol; 2020 Jul; 205(1):282-289. PubMed ID: 32471882
[TBL] [Abstract][Full Text] [Related]
4. Porphyromonas gingivalis suppresses oral squamous cell carcinoma progression by inhibiting MUC1 expression and remodeling the tumor microenvironment.
Lan Z; Zou KL; Cui H; Zhao YY; Yu GT
Mol Oncol; 2024 May; 18(5):1174-1188. PubMed ID: 37666495
[TBL] [Abstract][Full Text] [Related]
5. Oral squamous cell carcinoma-derived EVs promote tumor progression by regulating inflammatory cytokines and the IL-17A-induced signaling pathway.
Li R; Zhou Y; Zhang M; Xie R; Duan N; Liu H; Qin Y; Ma J; Li Z; Ye P; Wang W; Wang X
Int Immunopharmacol; 2023 May; 118():110094. PubMed ID: 37030119
[TBL] [Abstract][Full Text] [Related]
6. Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by stimulating the release of neutrophil extracellular traps in the tumor immune microenvironment.
Guo ZC; Jing SL; Jia XY; Elayah SA; Xie LY; Cui H; Tu JB; Na SJ
Inflamm Res; 2024 May; 73(5):693-705. PubMed ID: 38150024
[TBL] [Abstract][Full Text] [Related]
7. Interferon-stimulated gene 15 modulates cell migration by interacting with Rac1 and contributes to lymph node metastasis of oral squamous cell carcinoma cells.
Chen YL; Wu WL; Jang CW; Yen YC; Wang SH; Tsai FY; Shen YY; Chen YW
Oncogene; 2019 Jun; 38(23):4480-4495. PubMed ID: 30765861
[TBL] [Abstract][Full Text] [Related]
8. About a Possible Impact of Endodontic Infections by
Ciani L; Libonati A; Dri M; Pomella S; Campanella V; Barillari G
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791123
[TBL] [Abstract][Full Text] [Related]
9. The role of CXCL2-mediated crosstalk between tumor cells and macrophages in Fusobacterium nucleatum-promoted oral squamous cell carcinoma progression.
Nie F; Zhang J; Tian H; Zhao J; Gong P; Wang H; Wang S; Yang P; Yang C
Cell Death Dis; 2024 Apr; 15(4):277. PubMed ID: 38637499
[TBL] [Abstract][Full Text] [Related]
10. Periodontal pathogens promote cancer aggressivity via TLR/MyD88 triggered activation of Integrin/FAK signaling that is therapeutically reversible by a probiotic bacteriocin.
Kamarajan P; Ateia I; Shin JM; Fenno JC; Le C; Zhan L; Chang A; Darveau R; Kapila YL
PLoS Pathog; 2020 Oct; 16(10):e1008881. PubMed ID: 33002094
[TBL] [Abstract][Full Text] [Related]
11. SARI inhibits growth and reduces survival of oral squamous cell carcinomas (OSCC) by inducing endoplasmic reticulum stress.
Priyadarshini M; Maji S; Samal SK; Rath R; Li J; Das SK; Emdad L; Kundu CN; Fisher PB; Dash R
Life Sci; 2021 Dec; 287():120141. PubMed ID: 34774620
[TBL] [Abstract][Full Text] [Related]
12. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model.
Binder Gallimidi A; Fischman S; Revach B; Bulvik R; Maliutina A; Rubinstein AM; Nussbaum G; Elkin M
Oncotarget; 2015 Sep; 6(26):22613-23. PubMed ID: 26158901
[TBL] [Abstract][Full Text] [Related]
13. Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression.
Cao MX; Zhang WL; Yu XH; Wu JS; Qiao XW; Huang MC; Wang K; Wu JB; Tang YJ; Jiang J; Liang XH; Tang YL
J Exp Clin Cancer Res; 2020 Jun; 39(1):102. PubMed ID: 32493454
[TBL] [Abstract][Full Text] [Related]
14. Serum Levels of Interleukin-6 and Titers of Antibodies Against
Park DG; Woo BH; Lee BJ; Yoon S; Cho Y; Kim YD; Park HR; Song JM
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167516
[TBL] [Abstract][Full Text] [Related]
15. Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation.
Rai AK; Panda M; Das AK; Rahman T; Das R; Das K; Sarma A; Kataki AC; Chattopadhyay I
Arch Microbiol; 2021 Jan; 203(1):137-152. PubMed ID: 32783067
[TBL] [Abstract][Full Text] [Related]
16. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.
Liu R; Peng J; Wang H; Li L; Wen X; Tan Y; Zhang L; Wan H; Chen F; Nie X
Cell Physiol Biochem; 2018; 49(5):1717-1733. PubMed ID: 30231242
[TBL] [Abstract][Full Text] [Related]
17. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J
Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147
[TBL] [Abstract][Full Text] [Related]
18. An Acid-Responsive Iron-Based Nanocomposite for OSCC Treatment.
Zhao X; Leng D; Wang H; Jin H; Wu Y; Qin Z; Wu D; Wei X
J Dent Res; 2024 Jun; 103(6):612-621. PubMed ID: 38684484
[TBL] [Abstract][Full Text] [Related]
19. OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway.
Pang X; Wang SS; Zhang M; Jiang J; Fan HY; Wu JS; Wang HF; Liang XH; Tang YL
Cancer Immunol Immunother; 2021 Apr; 70(4):1015-1029. PubMed ID: 33104837
[TBL] [Abstract][Full Text] [Related]
20. [Periodontitis Promotes the Progression of Oral Squamous Cell Carcinoma by Inducing Macrophage M2 Polarization].
Li J; Wei W; Tang BY; Li Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):83-90. PubMed ID: 36647648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
